- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06040827
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Group 1 (Test): Zimmer Persona® Personalized Knee System with Canary canturioTM (CTE) tibial extension Group 2 (Control): Zimmer Persona® Personalized Knee System with 14 mm +30 mm stem extension Safety Endpoint The nature, severity, and frequency of safety risks in subjects with the Canary canturioTM te will be compared to those subjects with the legally marketed Zimmer Persona® Personalized Knee System with 14 mm x +30 mm stem extension within 5 years post-TKA.
The safety endpoint is the percentage of patients that meet any of the following criteria within 5 years post-TKA:
- Revision (tibia only)
- Aseptic loosening
- Instability (or unrecognized septic loosening)
- Intra-operative fracture of bone or device
- Post-operative fracture of bone or device
- Radiologic changes including:
- Lytic lines (radiolucency greater than 2 mm in 2 or more zones)
- Focal lysis(progressive osteolytic lesion)
- Osteolysis (3mm in more than 1 zone)
- Device fracture or failure (tibia only)
- Cortical thickening or periosteal reactions
Secondary Endpoints
The secondary endpoints (for 5 years post-TKA) are:
Successful Data Collection
- Percent of days with step-count data transmitted
- Percent of days with one or more gait bouts triggered and transmitted
- Percent of days with qualified gait cycles >0 (applicable for walking speed, stride length, tibia ROM, functional knee ROM and cadence)
- Percent of days with step-count data transmitted and qualified gait cycles >0 (applicable for distance) Pain and Functional Performance
- Knee Injury and Osteoarthritis Outcome Score (KOOS - JR)
- Numeric Pain Rating Scale (NPRS)
- Quality-of-life- EQ-5D-5L
Effectiveness Endpoints (Reliability, Reproducibility, and Accuracy) The reliability, precision and accuracy of walking speed using measurements at 1 year and 2 years post TKA will be assessed with a cohort of 75 patients from Group 1 (with the CTE). Additionally, the reliability, precision and accuracy of all 7 gait parameters (walking speed, cadence, stride length, functional knee ROM, tibia ROM, step count and distance) using measurements at 1 year with 3 different walking speeds, will be assessed with a consecutive cohort of 25 patients from Group 1 in a gait lab.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33607
- Foundation for Orthopaedic Research and Education
-
-
Indiana
-
South Bend, Indiana, United States, 46544
- South Bend Orthopaedics
-
-
Ohio
-
New Albany, Ohio, United States, 43054
- JIS Research Institute
-
-
South Carolina
-
Spartanburg, South Carolina, United States, 29303
- Carolina Orthopaedic & Neurosurgical Associates
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion
- Patient must be 18 years of age or older
- Patient qualifies for primary total knee arthroplasty based on physical exam and medical history, including diagnosis of severe knee pain and disability due to osteoarthritis, limited to:
- Mild or Moderate valgus, varus, or flexion deformities
- Patient must be willing and able to complete the protocol required follow-up
- Patient is indicated for a 58mm or 30mm tibial stem extension
- Patient has participated in the study-related informed consent process
- Patient is willing and able to provide written Informed Consent by signing and dating the IRB approved informed consent
- Patient has a platform-compatible personal computer located in their dwelling with appropriate wireless internet access and a USB port
- Independent of study participation, patient is a candidate for commercially available Persona Personalized Knee System implanted in accordance with product labeling
Exclusion
- Simultaneous bilateral TKA
- Staged bilateral TKA less than 6 months from indexed procedure
- Patient is a current alcohol or drug abuser
- Patient is known to be pregnant, breastfeeding, or considered a member of a protected class (e.g., prisoner, mentally incompetent, etc.)
- Patient has a psychiatric illness or cognitive deficit that will not allow proper informed consent and participation in follow-up program
- Patient has previous history of infection in the affected joint and/or a local or systemic infection that may affect the prosthetic joint
- Patient with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions
- Patient with skeletal immaturity
- Patient has insufficient bone stock on femoral or tibial surfaces
- Patient with Neuropathic Arthropathy
- Patient has osteoporosis, or any loss of musculature or neuromuscular disease that compromises the affected limb
- Patient has severe instability secondary to the absence of collateral ligament integrity.
- Patient has a stable, painless arthrodesis in a satisfactory functional position
- Patient has rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin
- Patient has a known or suspected sensitivity to one or more of the implant materials
- Patient is undergoing procedures or treatments using ionizing radiation
- Patients with known symptomatic foot, hip, or spinal injuries and/or conditions that could affect gait
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1 (Test)
Zimmer Persona® Personalized Knee System with Canary canturioTM (CTE) tibial extension
|
The nature, severity, and frequency of safety risks (Adverse Events) in subjects with the Canary canturioTM te will be compared to those subjects with the legally marketed Zimmer Persona® Personalized Knee System with 14 mm x +30 mm stem extension within 5 years post-TKA.
|
Group 2 ( Control)
Group 2 (Control): Zimmer Persona® Personalized Knee System with 14 mm +30 mm stem extension
|
The nature, severity, and frequency of safety risks (Adverse Events) in subjects with the Canary canturioTM te will be compared to those subjects with the legally marketed Zimmer Persona® Personalized Knee System with 14 mm x +30 mm stem extension within 5 years post-TKA.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety - Adverse Events
Time Frame: 5 years post TKA
|
The nature, severity, and frequency of safety risks (Adverse Events) in subjects with the Canary canturioTM te will be compared to those subjects with the legally marketed Zimmer Persona® Personalized Knee System with 14 mm x +30 mm stem extension within 5 years post-TKA.
|
5 years post TKA
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent of days with step-count data transmitted
Time Frame: 5 years post TKA
|
Successful Data Collection
|
5 years post TKA
|
Percent of days with one or more gait bouts triggered and transmitted
Time Frame: 5 years post TKA
|
Successful Data Collection
|
5 years post TKA
|
Percent of days with qualified gait cycles >0 (applicable for walking speed meter/second, stride length meter, tibia ROM, functional knee ROM and cadence)
Time Frame: 5 years post TKA
|
Successful Data Collection
|
5 years post TKA
|
Percent of days with step-count data transmitted and qualified gait cycles >0 (applicable for distance in meters)
Time Frame: 5 years post TKA
|
Successful Data Collection
|
5 years post TKA
|
Knee Injury and Osteoarthritis Outcome Score (KOOS - JR)
Time Frame: 5 years post TKA
|
Pain and Functional Performance
|
5 years post TKA
|
Numeric Pain Rating Scale (NPRS)
Time Frame: 5 years post TKA
|
Pain and Functional Performance
|
5 years post TKA
|
Quality-of-life- EQ-5D-5L
Time Frame: 5 years post TKA
|
Pain and Functional Performance
|
5 years post TKA
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PS220001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
Clinical Trials on Total Knee Arthroplasty
-
Technische Universität DresdenActive, not recruiting
-
Technische Universität DresdenMathys Ltd BettlachUnknownKnee Osteoarthritis
-
Jesus Moreta SuarezActive, not recruiting
-
Chang Gung Memorial HospitalUnknownComputer-assisted Navigation Versus Conventional Total Knee ReplacementTaiwan
-
Smith & Nephew, Inc.TerminatedDegenerative Arthritis of KneeUnited States, Australia
-
Technische Universität DresdenAesculap AGCompletedOsteoarthritis | Metal Ion LevelsGermany
-
MAKO Surgical Corp.CompletedOsteoarthritis | Rheumatoid Arthritis | Post-traumatic ArthritisUnited States
-
Singapore General HospitalCompleted
-
Nova Scotia Health AuthorityUnknown
-
Aesculap AGB.Braun Surgical SAActive, not recruitingKnee Osteoarthritis | Prosthesis-Related Infections | Prosthesis Failure | Bone; Deformity, CongenitalSpain